154 related articles for article (PubMed ID: 29856571)
1. Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics.
Murray RM; Di Forti M
World Psychiatry; 2018 Jun; 17(2):161-162. PubMed ID: 29856571
[No Abstract] [Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray RM; Quattrone D; Natesan S; van Os J; Nordentoft M; Howes O; Di Forti M; Taylor D
Br J Psychiatry; 2016 Nov; 209(5):361-365. PubMed ID: 27802977
[TBL] [Abstract][Full Text] [Related]
4. [25 years antipsychotics: back to the future?].
Denys D; de Haan L
Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
[TBL] [Abstract][Full Text] [Related]
5. The use of atypical antipsychotics in Bipolar Spectrum disorders.
Grünze H; Möller HJ
Indian J Psychiatry; 2003 Jan; 45(1):10-5. PubMed ID: 21206806
[TBL] [Abstract][Full Text] [Related]
6. The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.
Awad AG; Voruganti LN
CNS Drugs; 2013 Aug; 27(8):625-36. PubMed ID: 23757184
[TBL] [Abstract][Full Text] [Related]
7. New developments in the pharmacologic treatment of schizoaffective disorder.
Keck PE; McElroy SL; Strakowski SM
J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antipsychotic use for postoperative delirium: a systematic review and meta-analysis.
Hirota T; Kishi T
J Clin Psychiatry; 2013 Dec; 74(12):e1136-44. PubMed ID: 24434102
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of antipsychotics and their use in the treatment of schizophrenia. What's up, doc?].
Jufe GS
Vertex; 2011; 22(100):423-9. PubMed ID: 22799143
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism update for some recent antipsychotics.
Caccia S
Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):829-46. PubMed ID: 21476873
[TBL] [Abstract][Full Text] [Related]
11. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.
Smieskova R; Fusar-Poli P; Allen P; Bendfeldt K; Stieglitz RD; Drewe J; Radue EW; McGuire PK; Riecher-Rössler A; Borgwardt SJ
Curr Pharm Des; 2009; 15(22):2535-49. PubMed ID: 19689326
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Abraham D; Kissling W
Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
[TBL] [Abstract][Full Text] [Related]
13. Headache: what do children and mothers expect from pediatricians?
Raieli V; Compagno A; Pandolfi E; La Vecchia M; Puma D; La Franca G; Ragusa D
Headache; 2010 Feb; 50(2):290-300. PubMed ID: 20039963
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
Johnston AN; Bu W; Hein S; Garcia S; Camacho L; Xue L; Qin L; Nagi C; Hilsenbeck SG; Kapali J; Podsypanina K; Nangia J; Li Y
Breast Cancer Res; 2018 May; 20(1):42. PubMed ID: 29778097
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics: revolutionary or incremental advance?
Citrome L; Volavka J
Expert Rev Neurother; 2002 Jan; 2(1):69-88. PubMed ID: 19811017
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of expectations and knowledge in bariatric surgery patients.
Bauchowitz A; Azarbad L; Day K; Gonder-Frederick L
Surg Obes Relat Dis; 2007; 3(5):554-8. PubMed ID: 17702666
[TBL] [Abstract][Full Text] [Related]
17. How antipsychotics work: the patients' perspective.
Mizrahi R; Bagby RM; Zipursky RB; Kapur S
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):859-64. PubMed ID: 15908094
[TBL] [Abstract][Full Text] [Related]
18. EPS profiles: the atypical antipsychotics are not all the same.
Weiden PJ
J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.
Nasrallah HA; Newcomer JW
J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S7-14. PubMed ID: 15356415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
